biomarin pharmaceutical inc
(BMRN:NASDAQ GS)
As of 2:43 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).
Key Executives - biomarin pharmaceutical inc (BMRN)
| Name | Board Relationships | Title | Age |
| Jean-Jacques Bienaimé | 42 Relationships | Chief Executive Officer and Director | 58 |
| Daniel K. Spiegelman B.A., M.B.A. | 68 Relationships | Chief Financial Officer and Executive Vice President | 53 |
| Jeffrey Robert Ajer | No Relationships | Chief Commercial Officer and Senior Vice President | 50 |
| G. Eric Davis | No Relationships | Senior Vice President, Secretary and General Counsel | 41 |
| Henry J. Fuchs M.D., Ph.D. | 57 Relationships | Chief Medical Officer and Executive Vice President | 54 |
Board Members - biomarin pharmaceutical inc (BMRN)
| Name | Board Relationships | Primary Company | Age |
| Pierre Lapalme | 51 Relationships | DiagnoCure Inc. | 71 |
| Jean-Jacques Bienaimé | 42 Relationships | BioMarin Pharmaceutical Inc. | 58 |
| Alan J. Lewis Ph.D. | 78 Relationships | Medistem, Inc. | 66 |
| Richard A. Meier | 21 Relationships | Owens & Minor Inc. | 51 |
| William D. Young Ph.D. | 114 Relationships | NanoString Technologies, Inc. | 67 |
Executive Committees* - biomarin pharmaceutical inc (BMRN)
| Committee Name | Chairperson | Board Relationships | Members |
| Audit Committee | Richard A. Meier | 21 Relationships | 4 Executives |
| Compensation Committee | Kenneth M. Bate MBA | 58 Relationships | 3 Executives |
| Nominating Committee | William D. Young Ph.D. | 114 Relationships | 3 Executives |
| Corporate Governance Committee | William D. Young Ph.D. | 114 Relationships | 3 Executives |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| BMRN:US | $58.12 USD | -0.19 |  |
| Company | Last | Change |
| Alkermes PLC | $29.24 USD | -0.67 |
| Dendreon Corp | $4.05 USD | -0.03 |
| Jazz Pharmaceuticals Plc | $68.50 USD | -1.16 |
| Onyx Pharmaceuticals Inc | $86.50 USD | -2.30 |
| Spectrum Pharmaceuticals Inc | $8.26 USD | -0.02 |
| View Industry Companies | ||
Industry Analysis
BMRN
Industry Average
| Valuation | BMRN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 14.6x |
|
| Price/Book | 6.5x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 14.8x |
|
Post a JobJobs
- Novato, CA | BioMarin PharmaceuticalPosted: Jun 11
- San Rafael, CA | BioMarin PharmaceuticalPosted: Jun 11
- California | BioMarin PharmaceuticalPosted: Jun 11
- Novato, CA | BioMarin PharmaceuticalPosted: Jun 11
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
